Mark Cook

6.6k citations

89 papers · 2.8k · h-index 26

Impact in

Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Nephrology top 2%
- Renal Diseases and Glomerulopathies

Papers in

Hematology 53
- Multiple Myeloma Research and Treatments 41
- Hematopoietic Stem Cell Transplantation 8
Molecular Biology 30
- Amyloidosis: Diagnosis, Treatment, Outcomes 16
- Protein Degradation and Inhibitors 11

Co-authors: Paul Cockwell (27 shared papers)Paul Moss (13 shared papers)Colin A. Hutchison (16 shared papers)A.R. Bradwell (11 shared papers)Charles Craddock (17 shared papers)David Briggs (11 shared papers)Nelson Leung (4 shared papers)Robert A. Kyle (3 shared papers)
Journals: Blood (20 papers)British Journal of Haematology (5 papers)Journal of Clinical Oncology (5 papers)Bone Marrow Transplantation (4 papers)The Lancet Haematology (3 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Mark Cook

86 papers receiving 2.7k citations

Peers

Countries citing papers authored by Mark Cook

Since Specialization

Citations

This map shows the geographic impact of Mark Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cook more than expected).

Fields of papers citing papers by Mark Cook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cook. The network helps show where Mark Cook may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Cook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Cook Line = papers co-authored together Mark Cook links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML) Blood ·Oliver Goodyear, Mike Dennis, Nadira Jilani, Justin Loke, Shamyla Siddique, Gordon B. Ryan, Jane Nunnick, Rahela Khanum, Manoj Raghavan, Mark Cook, John A. Snowden, Mike Griffiths, Nigel H. Russell, John Yin, Charles Crawley, Gordon Cook, Paresh Vyas, Paul Moss, Ram Malladi, Charles Craddock	2012	307
2	How I treat monoclonal gammopathy of renal significance (MGRS) Blood ·Jean-Paul Fermand, Frank Bridoux, Robert A. Kyle, Efstathios Kastritis, Brendan M. Weiss, Mark Cook, Mark T. Drayson, Angela Dispenzieri, Nelson Leung	2013	229
3	Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma Journal of the American Society of Nephrology ·Colin A. Hutchison, Paul Cockwell, Steven D. Reid, Katie Chandler, Graham P. Mead, J. P. Harrison, John Hattersley, Neil D. Evans, Mike Chappell, Mark Cook, Hermann Goehl, Markus Storr, A.R. Bradwell	2007	196
4	Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia Journal of Clinical Oncology ·Sudhir Tauro, Charles Craddock, Karl S. Peggs, Gulnaz Begum, Premini Mahendra, Gordon Cook, Judith Marsh, Donald Milligan, Anthony P. Goldstone, Ann Hunter, Asim Khwaja, Raj Chopra, Timothy J. Littlewood, Andrew Peniket, Anne Parker, Graham Jackson, G Hale, Mark Cook, Nigel H. Russell, Stephen Mackinnon	2005	186
5	Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis Clinical Journal of the American Society of Nephrology ·Colin A. Hutchison, A.R. Bradwell, Mark Cook, Kolitha Basnayake, Supratik Basu, Stephen Harding, John Hattersley, Neil D. Evans, Mike J Chappel, Paul D. Sampson, Lukas Foggensteiner, Dwomoa Adu, Paul Cockwell	2009	177
6	Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney Journal of the American Society of Nephrology ·Colin A. Hutchison, Paul Cockwell, Stephanie Stringer, A.R. Bradwell, Mark Cook, Morie A. Gertz, Angela Dispenzieri, Jeffrey L. Winters, Shaji Kumar, S. Vincent Rajkumar, Robert A. Kyle, Nelson Leung	2011	159
7	The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia Blood ·Mark Cook, Donald Milligan, Chris Fegan, Philip Darbyshire, Premini Mahendra, Charles Craddock, Paul Moss, David Briggs	2003	157
8	Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation Blood ·Mark Cook	2005	144
9	Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis Nephrology Dialysis Transplantation ·Colin A. Hutchison, Nils Heyne, Parisa Airia, R Schindler, Daniel Zickler, Mark Cook, Paul Cockwell, Daniel Grima	2012	90
10	European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial Trials ·Colin A. Hutchison, Mark Cook, Nils Heyne, Katja Weisel, Lucinda Billingham, A.R. Bradwell, Paul Cockwell	2008	72
11	Current Trends of Renal Impairment in Multiple Myeloma Kidney Diseases ·Punit Yadav, Mark Cook, Paul Cockwell	2015	72
12	High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial The Lancet Haematology ·Colin A. Hutchison, Paul Cockwell, V. V. Moroz, A.R. Bradwell, Lesley Fifer, Julian D. Gillmore, Mark Jesky, Markus Storr, Julie Wessels, Christopher G. Winearls, Katja Weisel, Nils Heyne, Mark Cook	2019	71
13	Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT Bone Marrow Transplantation ·Batoul Pourgheysari, (unknown), Andrew McLarnon, Julie Arrazi, Rachel Bruton, Fiona Clark, Mark Cook, Premini Mahendra, Charles Craddock, Paul Moss	2008	70
14	Donor HLA-C Genotype Has a Profound Impact on the Clinical Outcome Following Liver Transplantation American Journal of Transplantation ·Raj Hanvesakul, Neil H. Spencer, Mark Cook, Bridget Gunson, Mark Hathaway, RM Brown, Peter Nightingale, Paul Cockwell, Stefan G. Hübscher, David Adams, Paul Moss, David Briggs	2008	58
15	The distribution of 13 killer‐cell immunoglobulin‐like receptor loci in UK blood donors from three ethnic groups European Journal of Immunogenetics ·Mark Cook, Paul Moss, David Briggs	2003	49
16	SNP haplotypes and allele frequencies show evidence for disruptive and balancing selection in the human leukocyte receptor complex Immunogenetics ·Paul J. Norman, Mark Cook, B. Sean Carey, Christine V. F. Carrington, David H. Verity, Kamran Hameed, D. Dan Ramdath, Dasnayanee Chandanayingyong, Mark Leppert, HenryA.F. Stephens, R. W. Vaughan	2004	49
17	Bortezomib, low‐dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma British Journal of Haematology ·Rakesh Popat, Heather Oakervee, Catherine Williams, Mark Cook, Charles Craddock, Supratik Basu, Charles R.J. Singer, Stephen Harding, Nicola Foot, Simon Hallam, Liz Odeh, Simon Joel, Jamie Cavenagh	2009	39
18	Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma Blood ·Oliver Goodyear, Guy Pratt, Andrew McLarnon, Mark Cook, Karen Piper Hanley, Paul Moss	2008	33
19	Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study Blood Cancer Journal ·Punit Yadav, Insara Jaffer Sathick, Nelson Leung, Elizabeth E. Brown, Mark Cook, Paul W. Sanders, Paul Cockwell	2020	33
20	Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations Human Immunology ·Ayman Antoun, Shirley Jobson, Mark Cook, Christopher A. O’Callaghan, Paul Moss, David Briggs	2010	29

About Mark Cook

Mark Cook is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Epidemiology, having authored 89 papers that have together received 2.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (41 papers), Immune Cell Function and Interaction (16 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), T-cell and B-cell Immunology (12 papers), Protein Degradation and Inhibitors (11 papers), Hematopoietic Stem Cell Transplantation (8 papers), CAR-T cell therapy research (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). The work is most often cited by research in Hematology (1.7k citations), Nephrology (266 citations), Immunology (749 citations), Genetics (280 citations) and Transplantation (58 citations). Mark Cook has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul Cockwell, Paul Moss, Colin A. Hutchison, A.R. Bradwell, Charles Craddock, David Briggs, Nelson Leung, Robert A. Kyle, Angela Dispenzieri and Premini Mahendra. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Bone Marrow Transplantation and The Lancet Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark Cook

Impact in

Papers in i

In The Last Decade

Mark Cook

Peers

Countries citing papers authored by Mark Cook

Fields of papers citing papers by Mark Cook

All Works

About Mark Cook

Explore authors with similar magnitude of impact

Papers in